Table 2

Prevalence of antibodies in serum samples from SS patients with or without anti-HTLV-I Abs

Anti-HTLV-I AbsRFANAAnti-SS-A/Ro AbsAnti-SS-B/La AbsACA
Seropositive group20/35 (57.1%)41/50 (82.0%)19/45 (42.2%)5/45 (11.1%)2/50 (4.0%)
Seronegative group61/103 (59.2%)153/182 (84.1%)74/124 (59.7%)18/124 (14.5%)27/136 (19.9%)
χ2testp=0.9862p=0.8935p=0.0654p=0.7502p=0.0158